Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy (METATONS)
Primary Purpose
Postoperative Pain
Status
Recruiting
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Methadone
Fentanyl
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring Postoperative pain, Methadone
Eligibility Criteria
Inclusion Criteria:
- All patients (≥18 years) scheduled for elective tonsillectomy
Exclusion Criteria:
- American Society of Anaesthesiologists (ASA) physical status IV or V
- Allergy to study drugs
- Daily use of opioids 7 days prior to surgery
- Inability to provide informed consent
- Severe respiratory insufficiency
- Heart failure
- Acute alcohol intoxication/delirium tremens
- Increased intracranial pressure
- Acute liver disease
- Liver insufficiency
- Kidney insufficiency
- Treatment with rifampicin
- Treatment with any drug prolonging the QT-interval
- Pregnancy (every female not using contraceptives will be screened with urine human choriogonadotropin)
- Breastfeeding
Sites / Locations
- Department of Anaesthesiology and Intensive CareRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Methadone
Fentanyl
Arm Description
Single-shot intravenous methadone 0.2 mg/kg administered intraoperatively
Single-shot intravenous fentanyl 3 microgram/kg administered intraoperatively
Outcomes
Primary Outcome Measures
Postoperative pain
Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)
Opioid consumption
Cumulative postoperative opioid consumption in morphine equivalents
Secondary Outcome Measures
Postoperative pain
Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)
Opioid consumption
Cumulative postoperative opioid consumption in morphine equivalents
Postoperative nausea and vomiting (none, mild, moderate, severe)
Nausea and/or vomiting (PONV), proportion of patients with none or mild PONV
Sedation
Level of sedation (Ramsay Scale (1-4)), proportion of patients being co-operative, oriented and tranquil
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05445856
Brief Title
Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy
Acronym
METATONS
Official Title
Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy - a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 28, 2022 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator
Detailed Description
This study is an investigator-initiated, prospective, randomised controlled trial with two arms: an intervention arm (methadone) and a control arm (fentanyl). Patients scheduled for tonsillectomy at Randers Regional Hospital, Denmark, will be approached for study participation.
Patients are randomised in a 1:1 ratio in blocks of varying sizes (between 4 and 8) to receive either intraoperative methadone or fentanyl. The randomisation assignment will be handled by the hospital pharmacy using a web-based central randomisation procedure (www.sealedenvelope.com).
The study drug will be prepared by the hospital pharmacy at Aarhus University Hospital and delivered as kits with identical appearance, marked with the randomization number (1-130). On the day of surgery, a kit will be opened and a 10 ml syringe with study drug (methadone 2 mg/ml or fentanyl 30 microgram/ml or ) will prepared by a health care professional (nurse or medical doctor not involved in the study or the treatment of patients). Once prepared, the blinded study drug will be given to and handled by one of the research team members and administered after induction of anesthesia and prior to surgery
The dose of the study drug will be administered as intravenous bolus dose in equipotent doses (0.2 mg/kg / 3 μg/kg) corresponding to 1 ml for every 10 kg of ideal body weight (women: height (cm) - 105. Men: height (cm) - 100)) after induction of anaesthesia and before the start of surgery.
Postoperative data will be obtained by reviewing hospital records, by interview and electronic questionnaires sent by email.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Postoperative pain, Methadone
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
130 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Methadone
Arm Type
Experimental
Arm Description
Single-shot intravenous methadone 0.2 mg/kg administered intraoperatively
Arm Title
Fentanyl
Arm Type
Active Comparator
Arm Description
Single-shot intravenous fentanyl 3 microgram/kg administered intraoperatively
Intervention Type
Drug
Intervention Name(s)
Methadone
Intervention Description
Methadone is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Intervention Description
Fentanyl is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery
Primary Outcome Measure Information:
Title
Postoperative pain
Description
Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)
Time Frame
On arrival at the post-anesthesia care unit
Title
Opioid consumption
Description
Cumulative postoperative opioid consumption in morphine equivalents
Time Frame
First 5 postoperative days
Secondary Outcome Measure Information:
Title
Postoperative pain
Description
Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)
Time Frame
1, 2, 3, 5 and 7 days after surgery
Title
Opioid consumption
Description
Cumulative postoperative opioid consumption in morphine equivalents
Time Frame
1 and 7 days after surgery
Title
Postoperative nausea and vomiting (none, mild, moderate, severe)
Description
Nausea and/or vomiting (PONV), proportion of patients with none or mild PONV
Time Frame
1, 2 and 3 days after surgery
Title
Sedation
Description
Level of sedation (Ramsay Scale (1-4)), proportion of patients being co-operative, oriented and tranquil
Time Frame
4 hours after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All patients (≥18 years) scheduled for elective tonsillectomy
Exclusion Criteria:
American Society of Anaesthesiologists (ASA) physical status IV or V
Allergy to study drugs
Daily use of opioids 7 days prior to surgery
Inability to provide informed consent
Severe respiratory insufficiency
Heart failure
Acute alcohol intoxication/delirium tremens
Increased intracranial pressure
Acute liver disease
Liver insufficiency
Kidney insufficiency
Treatment with rifampicin
Treatment with any drug prolonging the QT-interval
Pregnancy (every female not using contraceptives will be screened with urine human choriogonadotropin)
Breastfeeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael Bøndergaard, MD
Phone
004578420510
Email
michael.vinther@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Kristian Friesgaard, MD, PhD
Phone
00457842332
Email
k.friesgaard@me.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lone Nikolajsen, PhD, DMSc
Organizational Affiliation
Aarhus University Hospital, Department of Anesthesia and Intensive Care
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Anaesthesiology and Intensive Care
City
Randers
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Bøndergaard, MD
Phone
51326539
Email
michael.vinther@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
IPD will be shared upon reasonable request
Citations:
PubMed Identifier
28418966
Citation
Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Posterior Spinal Fusion Surgery: A Randomized, Double-blinded, Controlled Trial. Anesthesiology. 2017 May;126(5):822-833. doi: 10.1097/ALN.0000000000001609.
Results Reference
background
PubMed Identifier
25837528
Citation
Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, Parikh KN, Patel SS, Gupta DK. Intraoperative Methadone for the Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial in Cardiac Surgical Patients. Anesthesiology. 2015 May;122(5):1112-22. doi: 10.1097/ALN.0000000000000633.
Results Reference
background
PubMed Identifier
20418538
Citation
Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.
Results Reference
background
PubMed Identifier
22063370
Citation
Udelsmann A, Maciel FG, Servian DC, Reis E, de Azevedo TM, Melo Mde S. Methadone and morphine during anesthesia induction for cardiac surgery. Repercussion in postoperative analgesia and prevalence of nausea and vomiting. Rev Bras Anestesiol. 2011 Nov-Dec;61(6):695-701. doi: 10.1016/S0034-7094(11)70078-2. English, Multiple languages.
Results Reference
background
Learn more about this trial
Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy
We'll reach out to this number within 24 hrs